Therapies for Onychomycosis: A Review

Dermatologic Clinics

Volumn 24, Issue 3, 2006, Pages 375-379

  Gupta, Aditya K ^a,b   Tu, Linh Q ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b MEDIPROBE RESEARCH INC   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOROLFINE; ANTIFUNGAL AGENT; CICLOPIROX; FLUCONAZOLE; GRISEOFULVIN; IMIDAZOLE; ITRACONAZOLE; KETOCONAZOLE; TERBINAFINE; TRIAZOLE; UREA;

CLINICAL TRIAL; DEBRIDEMENT; DRUG EFFICACY; DRUG TOLERABILITY; FOOD AND DRUG ADMINISTRATION; HUMAN; ONYCHOMYCOSIS; PRIORITY JOURNAL; REVIEW; UNITED STATES;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANTIFUNGAL AGENTS; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; ONYCHOMYCOSIS;

EID: 33745496590     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2006.03.010     Document Type: Review

References (32)

1. Rich P. Special patient populations: onychomycosis in the diabetic patient. J Am Acad Dermatol 35 (1996) S10-S12
2. Goodridge D., Trepman E., and Embil J.M. Health-related quality of life in diabetic patients with foot ulcers: literature review. J Wound Ostomy Continence Nurs 32 (2005) 368-377
3. Denning D.W., Evans E.G., Kibbler C.C., et al. Fungal nail disease: a guide to good practice (report of a Working Group of the British Society for Medical Mycology). BMJ 311 (1995) 1277-1281
4. Elewski B.E. Onychomycosis caused by Scytalidium dimidiatum. J Am Acad Dermatol 35 (1996) 336-338
5. Markinson B.C., Monter S.I., and Cabrera G. Traditional approaches to treatment of onychomycosis. J Am Podiatr Med Assoc 87 (1997) 551-556
6. Daniel III C.R. Traditional management of onychomycosis. J Am Acad Dermatol 35 (1996) S21-S25
7. Hay R.J., Baran R., and Haneke E. Fungal (onychomycosis) and other infections involving the nail apparatus. In: Baran R., Dawber R.P.R., de Berker D.A.R., et al. (Eds). Baran and Dawber's diseases of the nails and their management (2001), Blackwell Science Ltd., Oxford 129-171
8. Bohn M., and Kraemer K. The dermatopharmacologic profile of ciclopirox 8% nail lacquer. J Am Podiatr Med Assoc 90 (2000) 491-494
9. Sigle H.C., Thewes S., Niewerth M., et al. Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans. J Antimicrob Chemother 55 (2005) 663-673
10. Dermik Laboratories. Penlac (ciclopirox) topical solution 8%: product monograph (2005), Dermik Laboratories, Berwyn (PA)
11. Reinel D., and Clarke C. Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weekly. Clin Exp Dermatol 17 Suppl 1 (1992) 44-49
12. Lauharanta J. Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly. Clin Exp Dermatol 17 Suppl 1 (1992) 41-43
13. Mensing H., Polak-Wyss A., and Splanemann V. Determination of the subungual antifungal activity of amorolfine after 1 month's treatment in patients with onychomycosis: comparison of two nail lacquer formulations. Clin Exp Dermatol 17 Suppl 1 (1992) 29-32
14. Reinel D. Topical treatment of onychomycosis with amorolfine 5% nail lacquer: comparative efficacy and tolerability of once and twice weekly use. Dermatology 184 Suppl 1 (1992) 21-24
15. Debruyne D., and Coquerel A. Pharmacokinetics of antifungal agents in onychomycoses. Clin Pharmacokinet 40 (2001) 441-472
16. Ryder N.S. Terbinafine: mode of action and properties of the squalene epoxidase inhibition. Br J Dermatol 126 Suppl 39 (1992) 2-7
17. Drake L., Babel D., Stewart D.M., et al. Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail. J Am Acad Dermatol 38 (1998) S87-S94
18. Evans E.G., and Sigurgeirsson B. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis: the LION Study Group. BMJ 318 (1999) 1031-1035
19. Gupta A.K., Maddin S., Arlette J., et al. Itraconazole pulse therapy is effective in dermatophyte onychomycosis of the toenail: a double-blind placebo-controlled study. J Dermatolog Treat 11 (2000) 33-37
20. Havu V., Brandt H., Heikkila H., et al. A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis. Br J Dermatol 136 (1997) 230-234
21. Heikkila H., and Stubb S. Long-term results in patients with onychomycosis treated with terbinafine or itraconazole. Br J Dermatol 146 (2002) 250-253
22. Ling M.R., Swinyer L.J., Jarratt M.T., et al. Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail. J Am Acad Dermatol 38 (1998) S95-S102
23. Scher R.K., Breneman D., Rich P., et al. Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail. J Am Acad Dermatol 38 (1998) S77-S86
24. Sigurgeirsson B., Olafsson J.H., Steinsson J.B., et al. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study. Arch Dermatol 138 (2002) 353-357
25. Warshaw E.M., Fett D.D., Bloomfield H.E., et al. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial. J Am Acad Dermatol 53 (2005) 578-584
26. Crawford F., Young P., Godfrey C., et al. Oral treatments for toenail onychomycosis: a systematic review. Arch Dermatol 138 (2002) 811-816
27. Gupta A.K., Ryder J.E., and Johnson A.M. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis. Br J Dermatol 150 (2004) 537-544
28. Haugh M., Helou S., Boissel J.P., et al. Terbinafine in fungal infections of the nails: a meta-analysis of randomized clinical trials. Br J Dermatol 147 (2002) 118-121
29. Zaias N., and Rebell G. The successful treatment of Trichophyton rubrum nail bed (distal subungual) onychomycosis with intermittent pulse-dosed terbinafine. Arch Dermatol 140 (2004) 691-695
30. Pavlotsky F., Armoni G., Shemer A., et al. Pulsed versus continuous terbinafine dosing in the treatment of dermatophyte onychomycosis. J Dermatolog Treat 15 (2004) 315-320
31. Sanmano B., Hiruma M., Mizoguchi M., et al. Combination therapy consisting of week pulses of oral terbinafine plus topical application of terbinafine cream in the treatment of onychomycosis. J Dermatolog Treat 15 (2004) 245-251
32. Foster K.W., Ghannoum M.A., and Elewski B.E. Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002. J Am Acad Dermatol 50 (2004) 748-752